Plasma cea levels in small cell lung cancer. Correlation with stage, distribution of metastases, and survival
β Scribed by Jacob J. Lokich
- Publisher
- John Wiley and Sons
- Year
- 1982
- Tongue
- English
- Weight
- 288 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To better understand whether replication-error-type instability (RER 1 ) is a frequent genetic alteration event in surgicalpathologic stage-I non-small-cell lung cancer (NSCLC) and identify whether it constitutes an independent prognostic parameter, we examined 35 surgical-pathologic stage-I-NSCLC p
## Background: In an attempt to improve treatment results of small cell lung cancer (sclc), combined induction chemotherapy and thoracic and prophylactic brain radiation therapy were administered. ## Method: From december 1980 to december 1987, 112 patients with limited-stage sclc were treated wi
p53 tumour suppressor gene alterations are one of the most frequent genetic events in lung cancer. A subset of patients with p53 mutation and cancer exhibited circulating serum anti-p53 self-antibodies (p53-Ab). The prevalence of these antibodies in lung cancer is currently being analysed in a multi